Disease | multiple myeloma |
Symptom | C0151825|bone pain |
Sentences | 4 |
PubMedID- 26038356 | Conclusions: ibandronate significantly reduces the incidence of skeletal-related events and bone pain in patients with mbd or multiple myeloma relative to placebo. |
PubMedID- 24649308 | The predominant clinical symptoms of multiple myeloma are associated with bone pain and renal dysfunction. |
PubMedID- 24133394 | bone pain affects 70% of multiple myeloma patients and is the most common symptom. |
PubMedID- 25793184 | In conclusion, we have reported a case of multiple myeloma presenting with bone pain and an illdefined osteolytic radiolucency in the maxilla as a first sign, reinforcing the fundamental role of dentomaxillofacial radiologists in the early recognition of oral lesions that reflect underlying systemic disease, thus preventing or reducing morbidity and mortality in such cases. |
Page: 1